Thomas Lowery

Dr. Thomas Lowery joined Satellite Bio in August of 2020 as Chief Technology Officer. Lowery is an experienced scientist, entrepreneur and executive. He brings 15 years of deep experience in product, process and analytical development and engineering as well as building highly productive technical and operational teams. Lowery has led technology innovation from inception through FDA to commercialization and clinical use for seven products that are currently in use in U.S. and international hospitals.

Prior to Satellite, Lowery was the Chief Scientific Officer at T2 Biosystems. He joined T2 as the first employee in February 2007, and built and led the technical teams from company launch through IPO and regulatory approval to worldwide commercialization. He has extensive experience in building, scaling and leading teams, product and test development in a regulated environment, developing manufacturing processes, working with regulatory agencies on first-in-class products, developing an intellectual property portfolio, completing multi-center clinical studies, and private, public and non-dilutive fundraising.

Lowery’s scientific achievements include 40 issued patents, 23 published patent applications, and 42 published peer-reviewed articles or book chapters. His publications span a diverse set of journals including Science, Clinical Chemistry, Protein Science, Blood, Science Translational Medicine, PNAS and Journal of the American Chemical Society.

Lowery earned his PhD in Biophysical Chemistry from the University of California, Berkeley and graduated Summa Cum Laude with a BS in Biochemistry and University Honors from Brigham Young University.